JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB15309

Anti-Glucose Transporter GLUT1 抗体

Anti-Glucose Transporter GLUT1 antibody

5

(15 Reviews)

|

(184 Publications)

Anti-Glucose Transporter GLUT1 antibody (ab15309) is a rabbit polyclonal antibody detecting Glucose Transporter GLUT1 in IHC-P, ICC/IF. Suitable for Human.

- Over 160 publications
- Trusted since 2004

別名を表示する

GLUT1, SLC2A1, HepG2 glucose transporter, GLUT-1

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Glucose Transporter GLUT1 antibody (AB15309)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Glucose Transporter GLUT1 antibody (AB15309)

ab15309 staining Glucose Transporter GLUT1 in human esophagous by Immunohistochemistry (FFPE-sections).

Immunocytochemistry/ Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)

ICC/IF image of ab15309 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab15309, 1μg/ml) overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti-rabbit IgG - H&L, pre-adsorbed (ab96899) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Glucose Transporter GLUT1 antibody (AB15309)
  • IHC-P

AbReview39480****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Glucose Transporter GLUT1 antibody (AB15309)

ab15309 staining Glucose Transporter GLUT1 (green) in Human red blood cells tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 1% BSA for 30 minutes at room temperature; antigen retrieval was by heat mediation in a citrate buffer, pH 6.0. Samples were incubated with primary antibody (1/500 in PBS-T + 1% PBS) for 12 hours. An Alexa Fluor® 488-conjugated Donkey anti-rabbit IgG polyclonal (1/500) was used as the secondary antibody. Red - autofluorescence of erythrocytes.

This image is courtesy of an Abreview submitted by Heiko Locher

Immunocytochemistry/ Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)
  • ICC/IF

AbReview4611****

Immunocytochemistry/ Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)

ab15309 at a 1/100 dilution staining rat cells (neural stem cells from adult subventricular zone) by Immunocytochemistry/Immunofluorescence. The cells were incubated with the antibody for 18 hours and then bound antibody was detected using a Cy3 conjugated Goat anti-rabbit IgG (H + L).

This image is courtesy of an Abreview submitted by Martin Maurer.

Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)
  • IF

CiteAb

Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)

Immunofluorescence using Anti-Glucose Transporter GLUT1 antibody, ab15309. Publication image from Jimenez-Orgaz, A. et al., 2018, EMBO J, 29158324. Legend direct from paper.

Control of RAB7 activity is not required for retromer‐based sorting of integral membrane proteinsAll images show formaldehyde‐fixed cells. Parental HeLa cells, VPS29 KO cells, and VPS29 KO cells transduced with the indicated VPS29 rescue constructs cells were co‐stained for endogenous GLUT1 (green) and endogenous LAMP2 (red), and co‐localization was quantified over three independent experiments.Parental HeLa cells, VPS29 KO cells, and VPS29 KO cells transduced with the indicated VPS29 rescue constructs were surface‐biotinylated, followed by streptavidin isolation and Western blot‐based quantification of biotinylated surface proteins. Surface GLUT1 was quantified over four independent experiments.RAB7a knockout cells and RAB7 KO cells transduced with the indicated GFP‐RAB7 rescue constructs cells were co‐stained for endogenous GLUT1 (red) and endogenous LAMP2 (blue), and co‐localization was quantified over two independent experiments.Parental HeLa cells, RAB7a knockout cells, and RAB7 KO cells transduced with the indicated GFP‐RAB7 rescue constructs were co‐stained for endogenous CI‐MPR (red) and endogenous TGN46 (blue).Data information : All scale bars = 10 µm, all error bars = SD, and *P < 0.05 in a t‐test of the respective condition compared to the control cells. Source data are available online for this figure.

Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)
  • IF

CiteAb

Immunofluorescence - Anti-Glucose Transporter GLUT1 antibody (AB15309)

Immunofluorescence using Anti-Glucose Transporter GLUT1 antibody, ab15309. Publication image from Jimenez-Orgaz, A. et al., 2018, EMBO J, 29158324. Legend direct from paper.

Control of RAB7 activity is not required for retromer‐based sorting of integral membrane proteinsAll images show formaldehyde‐fixed cells. Parental HeLa cells, VPS29 KO cells, and VPS29 KO cells transduced with the indicated VPS29 rescue constructs cells were co‐stained for endogenous GLUT1 (green) and endogenous LAMP2 (red), and co‐localization was quantified over three independent experiments.Parental HeLa cells, VPS29 KO cells, and VPS29 KO cells transduced with the indicated VPS29 rescue constructs were surface‐biotinylated, followed by streptavidin isolation and Western blot‐based quantification of biotinylated surface proteins. Surface GLUT1 was quantified over four independent experiments.RAB7a knockout cells and RAB7 KO cells transduced with the indicated GFP‐RAB7 rescue constructs cells were co‐stained for endogenous GLUT1 (red) and endogenous LAMP2 (blue), and co‐localization was quantified over two independent experiments.Parental HeLa cells, RAB7a knockout cells, and RAB7 KO cells transduced with the indicated GFP‐RAB7 rescue constructs were co‐stained for endogenous CI‐MPR (red) and endogenous TGN46 (blue).Data information : All scale bars = 10 µm, all error bars = SD, and *P < 0.05 in a t‐test of the respective condition compared to the control cells. Source data are available online for this figure.

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IHC-P, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p>See Abreview.</p>" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

製品の詳細

What is this antibody validated in?
Anti-Glucose Transporter GLUT1 antibody (ab15309) is a rabbit polyclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

Trusted by the scientific community
Anti-Glucose Transporter GLUT1 (ab15309) was first used in a scientific publication in 2004 and has been cited over 160 times in peer-reviewed journals.

Reviewed by scientists
Anti-Glucose Transporter GLUT1 (ab15309) has over 10 independent reviews from customers.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.4 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The Glucose Transporter GLUT1 also known as SLC2A1 is an important protein responsible for the transport of glucose across cell membranes. The GLUT1 transporter has a molecular weight of approximately 55 kDa. This protein is highly expressed in erythrocytes endothelial cells lining blood vessels and in the blood-brain barrier. Its primary role is to facilitate the basal glucose uptake necessary for cellular metabolism particularly in tissues where glucose is a critical energy source.
Biological function summary

This glucose transporter plays a significant role in maintaining glucose homeostasis in the human body. GLUT1 functions independently and not as part of a complex. It ensures that glucose is available to cells with high metabolic demands including the brain and red blood cells where it remains important for survival and function. Its expression level can be influenced by various factors including hypoxia and insulin.

Pathways

GLUT1 is involved in the glycolysis and hypoxia-related pathways. It supports the glycolytic pathway by ensuring a sufficient supply of glucose to the cells which is then metabolized to produce ATP. Additionally during hypoxic conditions GLUT1 expression can increase aligning with proteins like HIF-1α which helps cells adapt by modifying their metabolism. This coordinated regulation permits cells to adjust their energy systems according to the oxygen availability.

GLUT1 is implicated in glucose transporter type 1 deficiency syndrome (GLUT1 DS) and various forms of cancer. GLUT1 DS results from inadequate glucose transport into the brain presenting neurological symptoms due to energy deficiency. In cancer overexpression of GLUT1 links to increased glucose uptake and tumor growth a condition known to involve proteins like hexokinase. These associations underline GLUT1's contribution to both genetic defects and metabolic shifts in cancerous tissues.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed : 10227690, PubMed : 10954735, PubMed : 18245775, PubMed : 19449892, PubMed : 25982116, PubMed : 27078104, PubMed : 32860739). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed : 18245775, PubMed : 19449892). Most important energy carrier of the brain : present at the blood-brain barrier and assures the energy-independent, facilitative transport of glucose into the brain (PubMed : 10227690). In association with BSG and NXNL1, promotes retinal cone survival by increasing glucose uptake into photoreceptors (By similarity). Required for mesendoderm differentiation (By similarity).
See full target information SLC2A1

文献 (184)

Recent publications for all applications. Explore the full list and refine your search

Respiratory research 26:283 PubMed41044547

2025

GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Bo Broens,Conny J van der Laken,Teodora Radonic,Esther J Nossent,Xue D Manz,Douwe J Mulder,Yehya Al-Adwi,C Tji Gan,Wim Timens,Alexandre E Voskuyl,Jan Willem Duitman

iScience 28:113409 PubMed40995118

2025

N-glycosylation modulates the inactivation kinetics of the Kv3.4 ion channel.

Applications

Unspecified application

Species

Unspecified reactive species

Rajnish Ranjan,Emmanuelle Logette,Mirjia Herzog,Valerie Buchillier,Enrico Scantamburlo,Henry Markram

Nature communications 16:2553 PubMed40089463

2025

Spatiotemporally resolved mapping of extracellular proteomes via in vivo-compatible TyroID.

Applications

Unspecified application

Species

Unspecified reactive species

Zijuan Zhang,Yankun Wang,Wenjie Lu,Xiaofei Wang,Hongyang Guo,Xuanzhen Pan,Zeyu Liu,Zhaofa Wu,Wei Qin

Molecular and cellular endocrinology 595:112405 PubMed39481749

2024

An optimized fractionation method reveals insulin-induced membrane surface localization of GLUT1 to increase glycolysis in LβT2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Olivia Molinar-Inglis,Kiara Wiggins,Anjali Varma,Zena Del Mundo,Jose M Adame,Alyssa Cozzo,Oscar Muñoz,Uyen-Vy Le,Davina Trinh,Alexis C Garcia,Metztli Cisneros-Aguirre,Monica L Gonzalez Ramirez,Jeremiah Keyes,Jin Zhang,Mark A Lawson,JoAnn Trejo,Dequina A Nicholas

Oncology letters 28:593 PubMed39421321

2024

Expression of nuclear receptors and glucose metabolic pathway proteins in sebaceous carcinoma: Androgen receptor and monocarboxylate transporter 1 have a key role in disease progression.

Applications

Unspecified application

Species

Unspecified reactive species

Youn Joo Choi,Min Kyu Yang,Namju Kim,Sang In Khwarg,Hokyung Choung,Ji Eun Kim

PloS one 19:e0292655 PubMed38329960

2024

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie Kim,Jianning Ge,Dokyun Kim,Jae Jin Lee,Youn Jung Choi,Weiqiang Chen,James W Bowman,Suan-Sin Foo,Lin-Chun Chang,Qiming Liang,Daiki Hara,Inpyo Choi,Myung Hee Kim,Hyungjin Eoh,Jae U Jung

Endocrinology and metabolism (Seoul, Korea) 38:395-405 PubMed37533177

2023

Phloretin Ameliorates Succinate-Induced Liver Fibrosis by Regulating Hepatic Stellate Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Cong Thuc Le,Giang Nguyen,So Young Park,Hanh Nguyen Dong,Yun Kyung Cho,Jae-Ho Lee,Seung-Soon Im,Dae-Hee Choi,Eun-Hee Cho

Discover. Oncology 14:87 PubMed37273016

2023

ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Weihao Zhang,Yongjie Xie,Xin Yu,Changfu Liu,Wei Gao,Wenge Xing,Tongguo Si

Cell reports 42:112578 PubMed37267108

2023

Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.

Applications

Unspecified application

Species

Unspecified reactive species

Sinthu Pathmanapan,Raymond Poon,Tomasa Barrientos De Renshaw,Puviindran Nadesan,Makoto Nakagawa,Gireesh A Seesankar,Adrian Kwan Ho Loe,Hongyuan H Zhang,Joan J Guinovart,Jordi Duran,Christopher B Newgard,Jay S Wunder,Benjamin A Alman

Nature communications 14:2894 PubMed37210563

2023

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss.

Applications

Unspecified application

Species

Unspecified reactive species

Xianbing Zhu,Zheng Fu,Shary Y Chen,Dionzie Ong,Giulio Aceto,Rebecca Ho,Jutta Steinberger,Anie Monast,Virginie Pilon,Eunice Li,Monica Ta,Kyle Ching,Bianca N Adams,Gian L Negri,Luc Choiniere,Lili Fu,Kitty Pavlakis,Patrick Pirrotte,Daina Z Avizonis,Jeffrey Trent,Bernard E Weissman,Ramon I Klein Geltink,Gregg B Morin,Morag Park,David G Huntsman,William D Foulkes,Yemin Wang,Sidong Huang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com